Common ALS/FTD risk variants in UNC13A exacerbate its cryptic splicing and loss upon TDP-43 mislocalization

Variants within the UNC13A gene have long been known to increase risk of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD), two related neurodegenerative diseases defined by mislocalization of the RNA-binding protein TDP-43. Here, we show that TDP-43 depletion induces robust inclusion of a cryptic exon (CE) within UNC13A, a critical synaptic gene, resulting in nonsense-mediated decay and protein loss. Strikingly, two common polymorphisms strongly associated with ALS/FTD risk directly alter TDP-43 binding within the CE or downstream intron, increasing CE inclusion in cultured cells and in patient brains. Our findings, which are the first to demonstrate a genetic link specifically between loss of TDP-43 nuclear function and disease, reveal both the mechanism by which UNC13A variants exacerbate the effects of decreased nuclear TDP-43 function, and provide a promising therapeutic target for TDP-43 proteinopathies. One-Sentence Summary Shared ALS/FTD risk variants increase the sensitivity of a cryptic exon in the synaptic gene UNC13A to TDP-43 depletion.

[1]  Sven Rahmann,et al.  Sustainable data analysis with Snakemake , 2021, F1000Research.

[2]  Anna L. Brown,et al.  Truncated stathmin-2 is a marker of TDP-43 pathology in frontotemporal dementia. , 2020, The Journal of clinical investigation.

[3]  Anna L. Brown,et al.  FUS ALS-causative mutations impair FUS autoregulation and splicing factor networks through intron retention , 2020, Nucleic acids research.

[4]  Michael J. Bennett A Tale of Two Diseases , 2020 .

[5]  L. H. van den Berg,et al.  Pharmacogenetic interactions in amyotrophic lateral sclerosis: a step closer to a cure? , 2019, The Pharmacogenomics Journal.

[6]  J. Dittman Unc13: a multifunctional synaptic marvel , 2019, Current Opinion in Neurobiology.

[7]  B. Liu,et al.  UNC13A variant rs12608932 is associated with increased risk of amyotrophic lateral sclerosis and reduced patient survival: a meta-analysis , 2019, Neurological Sciences.

[8]  Eddie B. Lee,et al.  Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons , 2019, Cell reports.

[9]  Timothy A. Miller,et al.  Postmortem Cortex Samples Identify Distinct Molecular Subtypes of ALS: Retrotransposon Activation, Oxidative Stress, and Activated Glia , 2019, bioRxiv.

[10]  Kevin F. Bieniek,et al.  Genome-wide analyses as part of the international FTLD-TDP whole-genome sequencing consortium reveals novel disease risk factors and increases support for immune dysfunction in FTLD , 2019, Acta Neuropathologica.

[11]  Michael J. Steinbaugh,et al.  ALS IMPLICATED PROTEIN TDP-43 SUSTAINS LEVELS OF STMN2 A MEDIATOR OF MOTOR NEURON GROWTH AND REPAIR , 2019, Nature Neuroscience.

[12]  Michael S. Fernandopulle,et al.  CRISPR Interference-Based Platform for Multimodal Genetic Screens in Human iPSC-Derived Neurons , 2019, Neuron.

[13]  J. Trojanowski,et al.  UNC13A polymorphism contributes to frontotemporal disease in sporadic amyotrophic lateral sclerosis , 2019, Neurobiology of Aging.

[14]  Helen E. Parkinson,et al.  The NHGRI-EBI GWAS Catalog of published genome-wide association studies, targeted arrays and summary statistics 2019 , 2018, Nucleic Acids Res..

[15]  F. Rigo,et al.  Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration , 2018, Nature Neuroscience.

[16]  Nejc Haberman,et al.  Exon Junction Complex Shapes the Transcriptome by Repressing Recursive Splicing , 2018, Molecular cell.

[17]  Mark Gerstein,et al.  GENCODE reference annotation for the human and mouse genomes , 2018, Nucleic Acids Res..

[18]  Joshua F. McMichael,et al.  Integrated analysis of genomic and transcriptomic data for the discovery of splice-associated variants in cancer , 2018, bioRxiv.

[19]  Michael S. Fernandopulle,et al.  Transcription Factor–Mediated Differentiation of Human iPSCs into Neurons , 2018, Current protocols in cell biology.

[20]  Timothy A. Miller,et al.  Genome-wide Analyses Identify KIF5A as a Novel ALS Gene in and for Therapeutic , 2018 .

[21]  David A. Knowles,et al.  Annotation-free quantification of RNA splicing using LeafCutter , 2017, Nature Genetics.

[22]  Sheng Ding,et al.  Scalable Production of iPSC-Derived Human Neurons to Identify Tau-Lowering Compounds by High-Content Screening , 2017, Stem cell reports.

[23]  E. Buratti,et al.  Major hnRNP proteins act as general TDP-43 functional modifiers both in Drosophila and human neuronal cells , 2017, Nucleic acids research.

[24]  P. Corcia,et al.  ALS and frontotemporal dementia belong to a common disease spectrum. , 2017, Revue neurologique.

[25]  E. Eyras,et al.  IRFinder: assessing the impact of intron retention on mammalian gene expression , 2017, Genome Biology.

[26]  Xia Zhang,et al.  Genetics insight into the amyotrophic lateral sclerosis/frontotemporal dementia spectrum , 2017, Journal of Medical Genetics.

[27]  V. Plagnol,et al.  Quantitative analysis of cryptic splicing associated with TDP-43 depletion , 2016, bioRxiv.

[28]  C. Lewis,et al.  Rare genetic variation in UNC13A may modify survival in amyotrophic lateral sclerosis , 2016, Amyotrophic lateral sclerosis & frontotemporal degeneration.

[29]  J. Hodges,et al.  The frontotemporal dementia-motor neuron disease continuum , 2016, The Lancet.

[30]  A. Heger,et al.  UMI-tools: modeling sequencing errors in Unique Molecular Identifiers to improve quantification accuracy , 2016, bioRxiv.

[31]  Juan González-Vallinas,et al.  A new view of transcriptome complexity and regulation through the lens of local splicing variations , 2016, eLife.

[32]  Gabor T. Marth,et al.  A global reference for human genetic variation , 2015, Nature.

[33]  P. Wong,et al.  TDP-43 repression of nonconserved cryptic exons is compromised in ALS-FTD , 2015, Science.

[34]  G. Ermakova,et al.  Method for quantitative analysis of nonsense-mediated mRNA decay at the single cell level , 2015, Scientific Reports.

[35]  W. Huber,et al.  Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.

[36]  Max A. Horlbeck,et al.  Genome-Scale CRISPR-Mediated Control of Gene Repression and Activation , 2014, Cell.

[37]  A. Hofman,et al.  C9orf72 and UNC13A are shared risk loci for ALS and FTD: A genome-wide meta-analysis , 2014 .

[38]  J. Ule,et al.  Molecular basis of UG-rich RNA recognition by the human splicing factor TDP-43 , 2013, Nature Structural &Molecular Biology.

[39]  Brendan J. Frey,et al.  A compendium of RNA-binding motifs for decoding gene regulation , 2013, Nature.

[40]  Wei Shi,et al.  featureCounts: an efficient general purpose program for assigning sequence reads to genomic features , 2013, Bioinform..

[41]  Heng Li Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM , 2013, 1303.3997.

[42]  Steven L Salzberg,et al.  Fast gapped-read alignment with Bowtie 2 , 2012, Nature Methods.

[43]  P. Andersen,et al.  UNC13A is a modifier of survival in amyotrophic lateral sclerosis , 2012, Neurobiology of Aging.

[44]  E. Huey,et al.  FTD and ALS: a tale of two diseases. , 2011, Current Alzheimer research.

[45]  J. Ule,et al.  Characterizing the RNA targets and position-dependent splicing regulation by TDP-43. , 2011, Nature neuroscience.

[46]  M. DePristo,et al.  A framework for variation discovery and genotyping using next-generation DNA sequencing data , 2011, Nature Genetics.

[47]  M. DePristo,et al.  The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. , 2010, Genome research.

[48]  Michael Boehnke,et al.  LocusZoom: regional visualization of genome-wide association scan results , 2010, Bioinform..

[49]  Aaron R. Quinlan,et al.  BIOINFORMATICS APPLICATIONS NOTE , 2022 .

[50]  Ewout J N Groen,et al.  Genome-wide association study identifies 19p13.3 (UNC13A) and 9p21.2 as susceptibility loci for sporadic amyotrophic lateral sclerosis , 2009, Nature Genetics.

[51]  Gonçalo R. Abecasis,et al.  The Sequence Alignment/Map format and SAMtools , 2009, Bioinform..

[52]  F. Schmidt Meta-Analysis , 2008 .

[53]  Bruce L. Miller,et al.  Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis , 2006, Science.

[54]  F. Varoqueaux,et al.  Aberrant Morphology and Residual Transmitter Release at the Munc13-Deficient Mouse Neuromuscular Synapse , 2005, Molecular and Cellular Biology.

[55]  Christian Rosenmund,et al.  Total arrest of spontaneous and evoked synaptic transmission but normal synaptogenesis in the absence of Munc13-mediated vesicle priming , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[56]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[57]  V. Pasceri,et al.  A tale of two diseases: atherosclerosis and rheumatoid arthritis. , 1999, Circulation.

[58]  J. Haines,et al.  Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.

[59]  A. Velázquez‐Campoy,et al.  Isothermal titration calorimetry , 1990 .

[60]  Thomas R. Gingeras,et al.  STAR: ultrafast universal RNA-seq aligner , 2013, Bioinform..